A 48-year-old woman with stage IVB nasopharyngeal carcinoma (metastatic to lung and bone) is being considered for first-line palliative chemotherapy. She has normal renal function and good performance status (ECOG 0). Which drug regimen is the preferred first-line choice for metastatic NPC?